Study of patients who started taking blockbuster weight loss drugs in 2021 suggests patients need support services, not just ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...

The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from ...

A new study by researchers at Brigham and Women's Hospital in collaboration with researchers at Harvard T.H. Chan School of ...

A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present ...

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...

Among patients who took at least two doses of medication, GLP-1 receptor agonists were associated with a significantly lower ...

First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to ...

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...